Prior Anti-TNF-Alpha Exposure Is Associated with Ustekinumab Dose Escalation in Patients With Inflammatory Bowel Disease

被引：0
|
作者：
Tran, Nancy [1 ]
Lavergne, Alexa [1 ]
Scherl, Ellen [1 ]
Longman, Randy [1 ]
Lukin, Dana [1 ]
机构：
[1] Weill Cornell Med, Jill Roberts Ctr Inflammatory Bowel Dis, New York, NY USA
来源：
AMERICAN JOURNAL OF GASTROENTEROLOGY | 2023年 / 118卷 / 10期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
S1191
引用
下载
收藏
页码：S907 / S908
页数：2
相关论文
共 50 条
  • [11] COSTS OF DOSE ESCALATION AMONG PATIENTS WITH INFLAMMATORY BOWEL DISEASE TREATED WITH VEDOLIZUMAB AND USTEKINUMAB IN PORTUGAL
    Lopes da Cruz, J. P.
    Faria, M.
    Aleixo, A. S.
    Pereira, F.
    VALUE IN HEALTH, 2023, 26 (12) : S504 - S505
  • [12] Rate of Ustekinumab Dose Escalation in Patients With Crohn's Disease Who Had a History of Anti-TNF Dose Escalation
    Sun, Kelly
    Manski, Scott
    Crawford, Albert
    Shivashankar, Raina
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2023, 118 (12S): : S5 - S5
  • [13] De-escalation of biological therapy in inflammatory bowel disease patients following prior dose escalation
    Thomas, Pepijn W. A.
    Smits, Lisa J. T.
    Te Groen, Maarten
    West, Rachel L.
    Russel, Maurice G. V. M.
    Jansen, Jeroen M.
    Romkens, Tessa E. H.
    Hoentjen, Frank
    EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 2022, 34 (05) : 488 - 495
  • [14] Clinical and laboratory markers associated with anti-TNF-alpha trough levels and anti-drug antibodies in patients with inflammatory bowel diseases
    Grinman, Ana B.
    de Souza, Maria das Gracas C.
    Bouskela, Eliete
    Carvalho, Ana Teresa P.
    de Souza, Heitor S. P.
    MEDICINE, 2020, 99 (10) : E19359
  • [15] Treatment of inflammatory bowel disease patients with anti-TNF-alpha factors and immunosuppressives does not influence the prevalence of Helicobacter pylori infection
    Triantafillidis, John
    Gikas, Aristofanis
    Merikas, Emmanuel
    INDIAN JOURNAL OF GASTROENTEROLOGY, 2014, 33 (04) : 383 - 384
  • [16] Paradoxical psoriasiform reactions by anti-TNF treated with Ustekinumab in patients with inflammatory bowel disease
    Sahuquillo-Torralba, Antonio
    Pujol-Marco, Conrad
    Torres-Navarro, Ignacio
    Bastida-Paz, Guillermo
    Botella-Estrada, Rafael
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2019, 81 (04) : AB250 - AB250
  • [17] EFFECT OF ANTI-TNF-ALPHA TREATMENT ON SHORT-TERM POST-OPERATIVE COMPLICATIONS IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE
    Pugliese, D.
    Rizzo, G.
    Armuzzi, A.
    Verbo, A.
    Guidi, L.
    Andrisani, G.
    Manno, A.
    Papa, A.
    De Vitis, I.
    Mattana, C.
    Rapaccini, G.
    Coco, C.
    DIGESTIVE AND LIVER DISEASE, 2010, 42 : S137 - S137
  • [18] Vedolizumab is an effective alternative in inflammatory bowel disease patients with anti-TNF-alpha therapy-induced dermatological side effects
    Pijls, Philippe A. R. R.
    Gilissen, Lennard P. L.
    DIGESTIVE AND LIVER DISEASE, 2016, 48 (11) : 1391 - 1393
  • [19] PREVALENCE OF INFECTIONS IN PATIENTS AFFECTED BY INFLAMMATORY BOWEL DISEASE TREATED WITH ANTI-TNF-ALPHA AGENTS: A SINGLE-CENTER EXPERIENCE
    Imperatore, N.
    Foggia, M.
    Rispo, A.
    Patturelli, M.
    Calabrese, G.
    Testa, A.
    Nardone, O. M.
    Pellegrini, L.
    Guarino, A. D.
    Ricciolino, S.
    Tosone, G.
    Castiglione, F.
    DIGESTIVE AND LIVER DISEASE, 2020, 52 : S117 - S117
  • [20] Liver Injury Secondary to Anti-TNF-Alpha Therapy in Inflammatory Bowel Disease: A Case Series and Review of the Literature
    Parekh, Ravish
    Kaur, Nirmal
    CASE REPORTS IN GASTROINTESTINAL MEDICINE, 2014, 2014
12345